bêta
IA Trial Radar
L'essai clinique NCT07255131 (RAKITZIHCFA) pour Depression - Major Depressive Disorder, Anxiety Chronic, Anxiété, Résultat fonctionnel, Récupération, Obsessive Compulsive Disorders, Assertiveness est en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici.
Un essai clinique correspond aux filtres sélectionnés
Vue en carte

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program (RAKITZIHCFA)

En recrutement
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'essai' pour voir et discuter des informations sur l'essai dans la langue sélectionnée.
L'étude clinique NCT07255131 (RAKITZIHCFA) est un essai interventionnel pour Depression - Major Depressive Disorder, Anxiety Chronic, Anxiété, Résultat fonctionnel, Récupération, Obsessive Compulsive Disorders, Assertiveness. Son statut actuel est : en recrutement. L'étude a débuté le 26 septembre 2025 et vise à recruter 52 participants. Dirigé par Rakitzi, Stavroula, l'essai devrait être terminé d'ici le 20 décembre 2028. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 28 novembre 2025.
Résumé succinct
An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial
Description détaillée
A therapy group of patients with cystic fibrosis, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of patients with cystic fibrosis, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

A therapy group of caregivers, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of caregivers, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

Titre officiel

The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers in Comparison to Control Groups by the Hellenic Cystic Fibrosis Association A Randomized Controlled Trial

Conditions
Depression - Major Depressive DisorderAnxiety ChronicAnxiétéRésultat fonctionnelRécupérationObsessive Compulsive DisordersAssertiveness
Publications
Articles scientifiques et travaux de recherche publiés sur cet essai clinique:
Autres identifiants de l'essai
  • RAKITZIHCFA
  • RAKITZI CYSTIC FIBROSIS
  • HELLENIC CYSTIC FIBROSIS ASSOC (Autre Identifiant) (HELLENIC CYSTIC FIBROSIS ASSOCIATION & DR. STAVROULA RAKITZI)
Numéro NCT
Date de début (réel)
2025-09-26
Dernière mise à jour publiée
2025-11-28
Date de fin (estimée)
2028-12-20
Inscription (estimée)
52
Type d'essai
Interventionnel
PHASE
N/A
Statut
En recrutement
Mots clés
Cystic Fibrosis
Group cognitive behavioral psychotherapy
Objectif principal
Traitement
Plan d'attribution
Randomisé
Modèle d'intervention
Parallèle
Masquage
Simple aveugle
Bras / Interventions
Groupe de participants/BrasIntervention/Traitement
ExpérimentalTherapy group A patients with Cystic Fibrosis
Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.
Group a an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis
Comparateur actifControl group B Patients with cystic fibrosis
Participation on an online group supportive psychotherapy via Zoom in 13 sessions.
Group B an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis
ExpérimentalTherapy group C caregivers of patients with cystic fibrosis
Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.
Group C an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis
Comparateur actifContol group D caregivers of patients with cystic fibrosis
Participation on an online group supportive psychotherapy via Zoom in 13 sessions.
Group D an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis
Critère principal d'évaluation
Critères d'évaluationDescription de critèresPériode
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Preintervention
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Immediately after the intervention
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Follow-up up to 24 weeks
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Preintervention
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Immediately after intervention
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Follow-up up to 24 weeks
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Preintervention
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Immediately after intervention
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Follow-up up to 24 weeks
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Preintervention
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Immediately after the intervention
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Follow up up to 24 weeks
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Preintervention
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Immediately after the intervention
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Follow up up to 24 weeks
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Preintervention
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Immediately after the intervention
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Follow up up to 24 weeks
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Preintervention
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Immediately after intervention
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Follow up up to 24 weeks
Critères d'éligibilité

Âges éligibles
Adulte, Adulte âgé
Âge minimum
18 Years
Sexes éligibles
Tous
  • Age 18-70
  • Members of the Hellenic Cystic Fibrosis Association
  • Willingness to participate on 13 sessions via Zoom

  • Age over 70
  • Not members of the Hellenic Cystic Fibrosis Association
  • Not able to participate on 13 sessions via Zoom
Rakitzi, Stavroula logoRakitzi, Stavroula
Partie responsable de l'essai
Dr. Stavroula Rakitzi, Investigateur principal, PhD, Clinical psychologist and cognitive behavioral psychotherapist, Rakitzi, Stavroula
Contact central de l'essai
Contact: Dr. Stavroula Rakitzi, PhD, +306989766935, [email protected]
Contact: Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, +306944255853, [email protected]
1 Centres de l'essai dans 1 pays
Private practice, ILISION 34 15771 Athens Greece, Athens, 15771, Greece
Dr. Stavroula Rakitzi, PhD, Contact, +306989766935, [email protected]
Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, Contact, +306944255853, [email protected]
En recrutement